𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia

✍ Scribed by Kaiser, R; Tremblay, P-B; Klufmöller, F; Roots, I; Brockmöller, J

Book ID
110059415
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
145 KB
Volume
7
Category
Article
ISSN
1359-4184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No relationship betweenTaq1 a polymorphi
No relationship betweenTaq1 a polymorphism of dopamine D2 receptor gene and extrapyramidal adverse effects of selective dopamine D2 antagonists, bromperidol, and nemonapride in schizophrenia: A preliminary study
✍ Mihara, Kazuo ;Suzuki, Akihito ;Kondo, Tsuyoshi ;Nagashima, Udai ;Ono, Shingo ;O 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

The relationship between Taq1 A polymorphism of dopamine D 2 receptor (DRD 2 ) gene and extrapyramidal adverse effects of bromperidol and nemonapride, which are both antipsychotic drugs with selective and potent DRD 2 antagonistic property, was investigated in Japanese schizophrenic inpatients. Twen

Role of dopamine D3 receptor (DRD3) and
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia
✍ György Szekeres; Szabolcs Kéri; Anna Juhász; Ágnes Rimanóczy; István Szendi; Cso 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract Molecular components of the dopaminergic system may play an important role in the pathophysiology of schizophrenia. In this study, we investigated the relationship of the Ser9Gly (S/G) polymorphism of the dopamine D3 receptor (DRD3) and the variable number of tandem repeats (VNTR) polym